Diaryl ethers as opioid receptor antagonist

Details for Australian Patent Application No. 2003269980 (hide)

Owner Eli Lilly and Company

Inventors MItch, Charles Howard; Wolfe, Chad Nolan; Siegel, Miles Goodman; De La Torre, Marta Garcia; Stucky, Russell Dean; Quimby, Steven James; Matt, James Edward Junior; Diaz Buezo, Nuria; Takeuchi, Kumiko; Pedregal-Tercero, Concepcion; Holloway, William Glen; Blanco-Pillado, Maria-Jesus; Fritz, James Erwin; Smith, Dana Rae; Thomas, Elizabeth Marie; Chappell, Mark Donald

Agent Spruson & Ferguson

Pub. Number AU-B-2003269980

PCT Number PCT/US03/26300

PCT Pub. Number WO2004/026305

Priority 60/412,158 19.09.02 US

Filing date 17 September 2003

Wipo publication date 8 April 2004

Acceptance publication date 16 October 2008

International Classifications

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07C 235/46 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/643 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/78 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 217/04 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 237/24 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 241/24 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 307/14 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

15 January 2004 Complete Application Filed

  Priority application(s): 60/412,158 19.09.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-B-2003269980

16 October 2008 Application Accepted

  Published as AU-B-2003269980

27 November 2008 Corrigenda

  Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2003269980, under INID(72) correct the co-inventor name to Mitch, Charles Howard Corrigenda

12 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003269981-Method Of Creating Antigens Using Emus

2003269979-PROCESS FOR ENHANCING MATERIAL PROPERTIES AND MATERIALS SO ENHANCED